Melanoma is a type of skin cancer. When melanoma spreads to other parts of the body, it’s called metastatic melanoma, or stage IV melanoma. Some common sites for metastatic melanoma are the liver, lungs, bones, and brain.
Melanoma is a cancer of pigment-producing cells, melanocytes found in the skin, mucosa, and eyes. Melanoma results from DNA damage to skin cells, usually caused by exposure to ultraviolet rays from the sun or a tanning bed. The damage causes mutations that make the cells multiply rapidly, forming malignant tumors.
Melanomas are usually black or brown in color, and often resemble moles. They can also be skin-colored, red, bluish, or white. Melanoma is the most dangerous type of skin cancer.
Melanoma can spread to other tissues and organs of the body, including the lungs, liver, or the brain. Metastatic melanoma can fall into one of three categories: local recurrence, in transit metastasis, and nodal metastasis.
A local recurrence of melanoma is within 2 cm of the primary melanoma. It can occur by spread through the lymphatic vessels, or as an extension of the primary cancer. Metastases in transit are those found in the lymphatic vessels more than 2 cm from the primary site. Nodal metastasis is defined as melanoma that has spread to the lymph nodes.
Additionally, melanoma can be spread through the blood circulatory system. That occurs when a tumor invades a nearby blood vessel or it can be secondary to lymph node involvement. Melanoma can travel to distant sites in the body through the blood. This is called hematogenous spread of melanoma. Some common sites for metastatic melanoma are the lungs, skin, liver, and brain. Metastases can also form in the bone, gastrointestinal tract, heart, pancreas, kidneys, spleen, thyroid, and adrenal glands.
Some other rare presentations of melanoma include diffuse melanosis cutis and melanoma-associated vitiligo. In diffuse melanosis cutis, metastatic melanoma causes the entire skin surface to change color. Melanoma-associated vitiligo, also called melanoma-associated leukoderma, is a loss of pigment of the skin, resembling vitiligo, due to metastatic melanoma. Drugs that treat metastatic melanoma like immune checkpoint inhibitors and BRAF inhibitors can also cause melanoma-associated vitiligo.
Metastatic melanoma is diagnosed based on skin lesions and other signs such as enlarged lymph nodes. Symptoms of melanoma may include:
Tests used to diagnose metastatic melanoma include:
Metastatic melanoma may be treated as follows:
The risk of death from metastatic melanoma varies greatly by the location of the metastasis. Probability of death from a brain metastasis is twice that of a patient with digestive metastasis, and 7 fold greater than that of a patient with lung metastasis.